Europe’s biotechnology industry is finally beginning to catch up with the US,
according to the international consultancy Ernst & Young. Ken Lee, coauthor
of Ernst & Young’s annual snapshot of the industry, says that the US, with
1287 biotech companies in April 1997, still has the lead, although this figure
represents a drop of 2 per cent on the previous year. But Europe is expanding
rapidly, boasting 716 companies compared to 584 the year before.
More from 91av
Explore the latest news, articles and features
Physics
We need more radioactive drugs. Can we make them from nuclear waste?
Features
Technology
Table tennis-playing robot on track to becoming world champion
News
Health
Exercise advice for long covid may be doing more harm than good
Insight
Mathematics
Fermat's Last Theorem: still a must-read about a 350-year maths secret
Culture
Popular articles
Trending 91av articles
1
Brushing your teeth in hospital could prevent catching a bad infection
2
Exercise advice for long covid may be doing more harm than good
3
Fermat's Last Theorem: still a must-read about a 350-year maths secret
4
Why the right kind of stress is crucial for your health and happiness
5
We might finally know how to use quantum computers to boost AI
6
The biggest threat to Chernobyl is no longer radiation
7
If a bird flu pandemic starts, we may have an mRNA vaccine ready
8
Can we ‘vaccinate’ ourselves against stress?
9
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
10
The monstrous number sequences that break the rules of mathematics
